Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGruppo Italiano Malattie EMatologiche dell'Adulto

About this trial

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥ 18 years

Patients with primary ITP according to international criteria [2], who underwent to splenectomy from 01/01/2010 to 12/31/2022.

Obtaining Informed Consent.

Disqualifiers

none

Trial population

Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

evaluation of complications' incidence after splenectomy

Determine the percentage and incidence of thrombotic, hemorrhagic and infectious complications occurring during the patient's follow-up

Time frame
at 90 days

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: